Benzinga's Top Downgrades
Analysts at Benchmark downgraded Haemonetics (NYSE: HAE) from “buy” to “hold.” The target price for Haemonetics has been lowered from $49 to $46. Haemonetics shares closed at $42.54 yesterday.
Hilliard Lyons downgraded Franklin Electric Co (NASDAQ: FELE) from “buy” to “neutral.” Franklin Electric's shares closed at $45.42 yesterday.
Latest Ratings for HAE
|Feb 2017||Barrington Research||Downgrades||Outperform||Market Perform|
|Nov 2016||Barrington Research||Upgrades||Market Perform||Outperform|
|Aug 2016||Sidoti & Co.||Downgrades||Buy||Neutral|
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.